See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420030_2013_Targeted_Medical_Pharma_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001420030, Targeted Medical Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,598,813 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,318,619 |
| 2 | PropertyPlantAndEquipmentNet | 340,096 |
| 3 | remainder_Assets | 6,517,832 |
| 4 | LiabilitiesCurrent | 12,314,722 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,462,674 |
| 7 | CostOfGoodsAndServicesSold | 3,201,391 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,100,979 |
| 9 | ResearchAndDevelopmentExpense | 133,840 |
| 10 | remainder_Expenses | -3,185,938 |
| 11 | remainder_Revenues | 7,296,401 |
| 12 | remainder_NetIncome | -6,632,311 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 11,775,360 |
| 1 | Liabilities | 13,777,396 |
| 2 | Expenses | 10,250,272 |
| 3 | Revenues | 7,296,401 |
| 4 | StockholdersEquity | -2,002,036 |
| 5 | NetIncome | -9,586,182 |
| 6 | ComprehensiveNetIncome | -9,586,182 |
| 7 | BaseVar | 24,865,870 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.09 |
| 9 | EconomicCapitalRatio | 1.28 |
Edgar->Model Mapping
Feature Distribution
Change over Time
